MK-1092
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MK-1092, covering 2019-11-15 to 2019-11-15. Get the full timeline:
Most recent: Clinical Trial Update: Single Ascending Dose Study of MK-1092 in Healthy Participants and in Participants With Type 1 and Type 2 Diabetes Mellitus (MK-1092-001) [Phase 1]